Zobrazeno 1 - 10
of 5 546
pro vyhledávání: '"dry-powder inhaler"'
Autor:
Bajwa EK, Cislak D, Kumar A, Li D, Messina EJ, Reynders T, Denef JF, Corcea V, Buch KP, Lai E, Stoch SA
Publikováno v:
International Journal of COPD, Vol Volume 19, Pp 1105-1121 (2024)
Ednan K Bajwa,1 Dawn Cislak,1 Amit Kumar,1 Dan Li,1 Eric J Messina,1 Tom Reynders,2 Jean-François Denef,2 Vasile Corcea,3 Ketan P Buch,4 Eseng Lai,1 S Aubrey Stoch1 1MRL, Merck & Co., Inc., Rahway, NJ, USA; 2Translational Medicine, MSD Belgium, Brus
Externí odkaz:
https://doaj.org/article/7886eda8508e426b928876250387faa7
Autor:
Eman Zmaily Dahmash, Nour Radwan Achkar, Dalia Khalil Ali, Qais Jarrar, Affiong Iyire, Shereen M. Assaf, Hamad Alyami
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Fixed dose combinations (FDCs) incorporating two or three medicines in a single inhaler have been created to enhance patient compliance and hence clinical outcomes. However, the development of dry powder inhalers (DPIs), particularly for FDC
Externí odkaz:
https://doaj.org/article/5650efc3d16e4e6188d24badecda72d0
Autor:
Chinmoyee Borah, Trideep Saikia, Alakesh Bharali, Madhuchandra Lahan, Nikhil Biswas, Bhanu P Sahu
Publikováno v:
Drugs and Drug Candidates, Vol 3, Iss 1, Pp 275-290 (2024)
Despite various efforts, a successful selective delivery system for chemotherapeutic agents for lung cancer is still lacking. Dry powder inhaler (DPI) systems based on proliposomes (PLMs) could be a potential system for the efficient delivery of pacl
Externí odkaz:
https://doaj.org/article/0338f858b7df4e908d12513604caa714
Publikováno v:
Pulmonary Therapy, Vol 10, Iss 1, Pp 109-122 (2024)
Abstract Introduction The selection of inhaler device is of critical importance in chronic obstructive pulmonary disease (COPD) as the interaction between a patient’s inhalation profile and the aerosol characteristics of an inhaler can affect drug
Externí odkaz:
https://doaj.org/article/832681727c5c44aeb48ec95bd5e0d15e
Autor:
Annette Kainu, Ville A. Vartiainen, Witold Mazur, Hanna Hisinger-Mölkänen, Federico Lavorini, Christer Janson, Martin Andersson
Publikováno v:
Pulmonary Therapy, Vol 10, Iss 1, Pp 133-142 (2024)
Abstract Introduction There is increasing pressure to use environmentally friendly dry powder inhalers (DPI) instead of pressurized metered-dose inhalers (pMDI). However, correct inhalation technique is needed for effective inhaler therapy, and there
Externí odkaz:
https://doaj.org/article/1d5a561385b849b58a84d7ae8635fc90
Autor:
Ziyu Zhao, Wenhao Wang, Guanlin Wang, Zhengwei Huang, Liping Zhou, Li Lin, Yueling Ou, Wanzhen Huang, Xuejuan Zhang, Chuanbin Wu, Liang Tao, Qin Wang
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-17 (2023)
Abstract Background Gene therapy for lung cancer has emerged as a novel tumor-combating strategy for its superior tumor specificity, low systematical toxicity and huge clinical translation potential. Especially, the applications of microRNA shed led
Externí odkaz:
https://doaj.org/article/845412ffb376481194cf437070d1bdd8
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 16, Pp 1177-1186 (2023)
Fulvio Braido,1,2 Enrico Arnaboldi,1,2 Sara Barile,3 Luca Cavalieri,4 Eleonora Ingrassia,4 Maria Russo,1,2 Alessio Piraino4 1Respiratory Unit for Continuity of Care, IRCCS, Ospedale Policlinico San Martino, Genova, Italy; 2Department of Internal Medi
Externí odkaz:
https://doaj.org/article/3d2fa93e7f904d06befbe84f7a5d5b93
Publikováno v:
Pharmaceutics, Vol 16, Iss 8, p 1061 (2024)
Ivermectin (IVM), a drug originally used for treating parasitic infections, is being explored for its potential applications in cancer therapy. Despite the promising anti-cancer effects of IVM, its low water solubility limits its bioavailability and,
Externí odkaz:
https://doaj.org/article/b0df18690c004db383d6d91cdfe8b3bd
Publikováno v:
Pharmaceutics, Vol 16, Iss 8, p 980 (2024)
The inhaled delivery of lactic acid bacteria (LAB) probiotics has been demonstrated to exert therapeutic benefits to the lungs due to LAB’s immunomodulatory activities. The development of inhaled probiotics formulation, however, is in its nascent s
Externí odkaz:
https://doaj.org/article/a1fb26f406df4384b3511c891140ad54
Autor:
Alanood S. Almurshedi, Sarah N. Almarshad, Sarah I. Bukhari, Basmah N. Aldosari, Samiah A. Alhabardi, Fai A. Alkathiri, Imran Saleem, Noura S. Aldosar, Randa Mohammed Zaki
Publikováno v:
Pharmaceutics, Vol 16, Iss 7, p 897 (2024)
Invasive pulmonary aspergillosis (IPA) is a fatal fungal infection with a high mortality rate. Voriconazole (VCZ) is considered a first-line therapy for IPA and shows efficacy in patients for whom other antifungal treatments have been unsuccessful. T
Externí odkaz:
https://doaj.org/article/8721103b2b2f4bb696ea72523ad72590